04/03/2025
New from RxLaw: What Trump’s tariffs mean for Canadian pharmacists and healthcare professionals.
The U.S. has announced sweeping trade measures—with only a temporary exemption for pharmaceuticals. But for Canadian healthcare, that’s not enough.
In the first edition of Pulse by RxLaw, I break down how these tariffs could:
Disrupt Canada’s pharmaceutical supply chains
Drive up medication costs
Trigger legal and regulatory risks for healthcare institutions
Pulse by RxLaw is our new regulatory strategy and foresight series.
Some law firms send newsletters. We publish Pulse.
This is essential reading for pharmacists, regulators, and healthcare leaders preparing for what’s next.
📄 Read the full article here: https://www.linkedin.com/pulse/trump-tariffs-coming-heres-what-pharmacists-healthcare-leaders-vsazc
Most law firms publish newsletters. RxLaw delivers foresight.
